Answers are grounded in this paper and cite their sources.
Canagliflozin lowered RT(G) and increased UGE, improved glycemic control and beta-cell function in rodent models of T2DM, and reduced body weight gain in rodent models of obesity.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: